What are the possible causes of a sensory-predominant peripheral neuropathy in a 70-year-old man with a history of coronary artery bypass grafting, hypertension, smoking, and no diabetes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Causes of Sensory-Predominant Peripheral Neuropathy

In a 70-year-old man with coronary artery bypass grafting, hypertension, and smoking history but no diabetes, the most important causes to evaluate are: vascular/ischemic neuropathy (given his significant atherosclerotic disease), vitamin B12 deficiency, hypothyroidism, alcohol use, renal insufficiency, and vasculitic neuropathy—with his cardiovascular disease history being a particularly strong risk amplifier for ischemic peripheral neuropathy.

Primary Diagnostic Considerations

Vascular/Ischemic Neuropathy

Given this patient's cardiovascular profile, ischemic neuropathy from peripheral arterial disease is a critical consideration. Coronary artery disease is a significant risk factor for ischemic peripheral neuropathy 1. Studies show that 82.7% of patients with peripheral arterial occlusive disease have peripheral neuropathy, with ischemic neuropathy accounting for 23.1% of cases 1. The presence of coronary artery disease specifically increases risk for ischemic peripheral neuropathy (P=0.01) 1.

Hypertension-Related Neuropathy

Hypertension itself can cause peripheral sensory neuropathy independent of diabetes 2. Research demonstrates that nondiabetic hypertensive patients show increased current perception threshold values on peroneal nerve testing compared to controls, suggesting that vascular factors play an essential role in neuropathy development even without diabetes 2. This is particularly relevant given your patient's documented hypertension and supports the concept that "typical complications of diabetes can be observed in nondiabetic hypertensives" 2.

Surgical Complications

Post-CABG peripheral neuropathy occurs in approximately 13% of patients 3. While most commonly presenting as brachial radiculoplexopathy (affecting 23 of 421 patients), other manifestations include saphenous (13 cases), common peroneal (8 cases), and ulnar mononeuropathies (5 cases) 3. Males and patients exposed to hypothermia during surgery face increased risk 3. Most deficits are transient, though this should be considered in the differential.

Essential Metabolic and Toxic Causes to Exclude

The following must be systematically evaluated, as they are treatable causes 4:

  • Vitamin B12 deficiency - Common and reversible
  • Hypothyroidism - Frequently overlooked metabolic cause
  • Renal insufficiency - Creates metabolic toxicants damaging nerves; particularly important given cardiovascular disease burden
  • Alcohol abuse - Critical toxic exposure to assess
  • Neurotoxic medications - Review all current medications, particularly statins (which rarely cause painful neuropathic syndrome) 5

Inflammatory and Autoimmune Causes

Vasculitic Neuropathy

Vasculitis is a frequent cause of neuropathy, particularly in older patients with cardiovascular risk factors 6. This presents as asymmetric, progressive sensory-motor involvement and requires nerve biopsy for definitive diagnosis when non-invasive tests are inconclusive 7. The 2020 ESMO guidelines emphasize that autoimmune rheumatologic conditions predispose to neuropathy 8.

Other Inflammatory Conditions

  • Chronic inflammatory demyelinating neuropathy
  • HIV infection (must be screened)
  • Hepatitis C virus 6

Malignancy-Related Causes

Evaluate for:

  • Multiple myeloma - Classic association with sensory neuropathy
  • Bronchogenic carcinoma - Particularly relevant given smoking history
  • Paraneoplastic syndromes 4

Clinical Pattern Recognition

The fiber type affected determines symptom presentation 8:

Large Fiber Involvement

  • Numbness in "glove and stocking" distribution
  • Impaired vibration perception (tuning fork test)
  • Loss of proprioception
  • Reduced/absent deep tendon reflexes
  • Ataxia 9

Small Fiber Involvement

  • Burning pain in feet/hands
  • Lancinating pain
  • Decreased pain and temperature sensation
  • Dysesthesia, allodynia, hyperalgesia 8

Diagnostic Algorithm

Electrophysiologic testing with nerve conduction studies is essential unless clinical features are typical for a known cause 4. The 2018 ADA guidelines state that electrophysiological testing is "rarely needed, except in situations where the clinical features are atypical or the diagnosis is unclear" 4.

Required Laboratory Evaluation

  • Complete blood count
  • Comprehensive metabolic panel (renal function)
  • Vitamin B12 level
  • Thyroid function tests
  • Hemoglobin A1c (to definitively exclude diabetes)
  • Serum protein electrophoresis (myeloma screening)
  • HIV testing
  • Hepatitis C screening
  • Erythrocyte sedimentation rate/C-reactive protein (vasculitis screening)

When to Pursue Nerve Biopsy

Consider nerve biopsy when routine screening is negative and clinical suspicion for vasculitis or unusual disorders remains high 6, 7. This is particularly important as PET scanning may miss active vasculitic features that biopsy reveals 7.

Critical Pitfalls to Avoid

  1. Do not assume diabetic neuropathy without confirmed diabetes - Multiple other causes exist in this demographic
  2. Do not overlook treatable causes - B12 deficiency, hypothyroidism, and vasculitis require specific interventions
  3. Do not ignore the cardiovascular-neuropathy connection - Polyvascular disease significantly amplifies neuropathy risk 10
  4. Do not forget medication review - Statins and other cardiovascular medications can rarely cause neuropathy 5

Special Consideration: Idiopathic Neuropathy

Idiopathic sensory polyneuropathy should only be diagnosed after excluding all identifiable causes 9, 6. Given this patient's significant cardiovascular disease burden, vascular etiology should be thoroughly investigated before labeling the neuropathy as idiopathic.

References

Research

Diagnosis and management of sensory polyneuropathy.

BMJ (Clinical research ed.), 2019

Related Questions

In a 67-year-old man with peripheral arterial disease, uncontrolled systolic hypertension (145-155 mm Hg) and heart rate 80-90 bpm who is already on a statin and aspirin, which second antihypertensive agent is preferred: an ACE inhibitor, an angiotensin‑II receptor blocker, a selective β‑blocker, a dihydropyridine calcium‑channel blocker, or a potassium‑sparing diuretic?
In a 71-year-old woman with hypertension and coronary artery disease who has a dry, persistent cough and exercise‑induced chest tightness, with normal spirometry and normal chest radiograph, what is the best next step in management?
What is the appropriate evaluation and management for acute bilateral lower extremity sensory impairment?
Are left ventricular hypertrophy, a dilated left atrium, and mild mitral and pulmonic regurgitation classified as high atherosclerotic cardiovascular disease (ASCVD) risk?
How should I evaluate and manage a 70-year-old male, post‑coronary artery bypass graft, hypertensive smoker, non‑diabetic, with six‑month bilateral burning foot pain unresponsive to gabapentinoids and a new resting right‑leg tremor?
What are the potential benefits and risks of using chanca piedra (Phyllanthus niruri) tea in patients with chronic kidney disease who have diabetes mellitus and are on insulin therapy?
How should I evaluate and manage a 70-year-old male, post‑coronary artery bypass graft, hypertensive smoker, non‑diabetic, with six‑month bilateral burning foot pain unresponsive to gabapentinoids and a new resting right‑leg tremor?
Which validated tool should be used to screen and assess severity of depression in adults?
What patient education should be provided to a patient with hypothyroidism regarding levothyroxine therapy, including dosing, administration, monitoring, side effects, and follow‑up?
How should refractory gastroesophageal reflux disease and gastritis with intestinal metaplasia be managed?
In a 59-year-old woman with a 3.5 × 3.3 × 3.3 cm rim‑enhancing mass at the pancreatic neck‑body junction that is predominantly non‑enhancing centrally, shows a delayed‑enhancing thick capsule with wall nodularity, no other sites involved, normal tumor markers except an elevated CA‑125, and a normal transvaginal ultrasound, what is the next step in management?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.